Quitting by Gradual Smoking Reduction Using Nicotine Gum. A Randomized Controlled Trial

American Journal of Preventive Medicine

Volumn 36, Issue 2, 2009, Pages

  Shiffman, Saul ^a   Ferguson, Stuart G ^a   Strahs, Kenneth R ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE GUM; NON PRESCRIPTION DRUG; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEARTBURN; HICCUP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 58149288238     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2008.09.039     Document Type: Article

References (39)

1. Peto R. Smoking and death: the past 40 years and the next 40. BMJ 309 (1994) 937-939
2. CDC. Cigarette smoking among adults-United States, 2000. MMWR 51 (2002) 642-645
3. Shiffman S., Brockwell S.E., Pillitteri J.L., and Gitchell J.G. Use of smoking-cessation treatments in the United States. Am J Prev Med 34 (2008) 102-111
4. Fiore M.C. Treating tobacco use and dependence: an introduction to the U.S. Public Health Service Clinical Practice Guideline. Respir Care 45 (2000) 1196-1199
5. Garvey A.J., Bliss R.E., Hitchcock J.L., Heinold J.W., and Rosner B. Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict Behav 17 (1992) 367-377
6. Hughes J.R., Gulliver S.B., Fenwick J.W., et al. Smoking cessation among self-quitters. Health Psychol 11 (1992) 331-334
7. Silagy C., Lancaster T., Stead L., Mant D., and Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3 (2004) CD000146
8. Hughes J.R., Callas P.W., and Peters E.N. Interest in gradual cessation. Nicotine Tob Res 9 (2007) 671-675
9. Shiffman S., Hughes J.R., Ferguson S.G., Pillitteri J.L., Gitchell J.G., and Burton S.L. Smokers' interest in using nicotine replacement to aid smoking reduction. Nicotine Tob Res 9 (2007) 1177-1182
10. Cheong Y., Yong H.H., and Borland R. Does how you quit affect success?. A comparison between abrupt and gradual methods using data from the International Tobacco Control Policy Evaluation Study. Nicotine Tob Res 9 (2007) 801-810
11. Peters E.N., Hughes J.R., Callas P.W., and Solomon L.J. Goals indicate motivation to quit smoking. Addiction 102 (2007) 1158-1163
12. Shiffman S., Gitchell J., Pinney J.M., Burton S.L., Kemper K.E., and Lara E.A. Public health benefit of over-the-counter nicotine medications. Tob Control 6 (1997) 306-310
13. Rose J.E., and Behm F.M. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine Tob Res 6 (2004) 523-532
14. Carpenter M.J., Hughes J.R., and Keely J.P. Effect of smoking reduction on later cessation: a pilot experimental study. Nicotine Tob Res 5 (2003) 155-162
15. Cinciripini P.M., Lapitsky L.G., Wallfisch A., Mace R., Nezami E., and Van Vunakis H. An evaluation of a multicomponent treatment program involving scheduled smoking and relapse prevention procedures: initial findings. Addict Behav 19 (1994) 13-22
16. Cinciripini P.M., Lapitsky L., Seay S., Wallfisch A., Kitchens K., and Van Vunakis H. The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal?. J Consult Clin Psychol 63 (1995) 388-399
17. Levinson B.L., Shapiro D., Schwartz G.E., and Tursky B. Smoking elimination by gradual reduction. Behavior Therapy 2 (1971) 477-487
18. West R., and Shiffman S. Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacology (Berl) 155 (2001) 115-122
19. Shiffman S., Ferguson S.G., Gwaltney C.J., Balabanis M.H., and Shadel W.G. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy. Psychopharmacology (Berl) 184 (2006) 637-644
20. Cooper T., and Clayton R. New hope for heavy smokers: the cooper/clayton method for stop smoking (1988), SBC Publishers, Lexington
21. Hughes J.R., and Carpenter M.J. The feasibility of smoking reduction: an update. Addiction 100 (2005) 1074-1089
22. Fagerstrom K.O. Can reduced smoking be a way for smokers not interested in quitting to actually quit?. Respiration 72 (2005) 216-220
23. Committee on Safety of Medicines and Healthcare Products Regulatory Agency (CSMHPRA). Report of the committee on safety of medicines working group on nicotine replacement therapy 2006. London, CSM & MHRSA. www.mhra.gov.uk.
24. Brown R., Burgess E., Sales S., Whitely J., Evans D., and Miller I. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav 12 (1998) 101-112
25. Shields P.G. Tobacco smoking, harm reduction, and biomarkers. J Natl Cancer Inst 94 (2002) 1435-1444
26. Benowitz N.L., Kuyt F., and Jacob III P. Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther 32 (1982) 758-764
27. Junge B. Changes in serum thiocyanate concentration on stopping smoking. Br Med J (Clin Res Ed) 291 (1985) 22
28. U.S. Food and Drug Administration. Transcript of the Joint Meeting of the Non-prescription Drugs Advisory Committee and the Drug Abuse Advisory Committee of the Food and Drug Administration.
29. Shiffman S., Rolf C.N., Hellebusch S.J., et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction 97 (2002) 505-516
30. Wang D., Connock M., Barton P., Fry-Smith A., Aveyard P., and Moore D. Cut down to quit with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess 12 (2008) iii-iv, ix-xi, 1-135
31. Hammond D., Fong G.T., Cummings K.M., and Hyland A. Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev 14 (2005) 1370-1375
32. Schwartz J.L. Review and evaluation of smoking cessation methods: the United States and Canada, 1978-1985 (1987), U.S. Government Printing Office, Washington DC
33. Shiffman S., Scharf D.M., Shadel W.G., et al. Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol 74 (2006) 276-285
34. Shiffman S. Use of more nicotine lozenges leads to better success in quitting smoking. Addiction 102 (2007) 809-814
35. Abrams D.B., Niaura R., Brown R.A., Emmons K.M., Goldstein M.G., and Monti P.M. Tobacco dependence treatment handbook: a guide to best practices (2003), Guilford Press, New York
36. Shiffman S., Paty J.A., Rohay J.M., Di Marino M.E., and Gitchell J. The efficacy of computer-tailored smoking cessation material as a supplement to nicotine polacrilex gum therapy. Arch Intern Med 160 (2000) 1675-1681
37. Nemeth-Coslett R., and Henningfield J.E. Effects of nicotine chewing gum on cigarette smoking and subjective and physiologic effects. Clin Pharmacol Ther 39 (1986) 625-630
38. Murray R.P., Bailey W.C., Daniels K., et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 109 (1996) 438-445
39. Mahmarian J.J., Moye L.A., Nasser G.A., et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol 30 (1997) 125-130